MicroQuin Secures DoD CDMRP Grant to Advance Traumatic Brain Injury Treatment Innovations

Traumatic Brain Injury (TBI) remains a major health challenge, especially for military personnel exposed to combat and training environments. The Department of Defense (DoD) has long prioritized research to improve outcomes for those affected by TBI. Recently, MicroQuin, a company focused on developing medical treatments, received a significant grant from the DoD’s Congressionally Directed Medical Research Programs (CDMRP). This funding will support the development of new therapies aimed at improving recovery and quality of life for individuals suffering from TBI.

MicroQuin laboratory equipment for TBI treatment development